Advertisement

Topics

Gene Therapy Platforms May Require Less Preclinical Data, Gottlieb Says

19:36 EDT 7 Sep 2017 | SCRIP

US FDA's preclinical policies should be 'more closely matched to the complexion of modern technologies,' commissioner explains.

      

Related Stories

 

Original Article: Gene Therapy Platforms May Require Less Preclinical Data, Gottlieb Says

NEXT ARTICLE

More From BioPortfolio on "Gene Therapy Platforms May Require Less Preclinical Data, Gottlieb Says"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...